Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

about

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

Item

http://www.wikidata.org/entity/Q42678620

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@en

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@nl

type

Item

label

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@en

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@nl

prefLabel

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@en

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@nl

P1476

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective.

@en

P2093

Meet Kumar

http://www.w3.org/2001/XMLSchema#string

Pinaki Mukherjee

http://www.w3.org/2001/XMLSchema#string

Prakas Mandal

http://www.w3.org/2001/XMLSchema#string

Rajib De

http://www.w3.org/2001/XMLSchema#string

Tuphan Kanti Dolai

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical hemolytic uremic syndrome

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.

Management of hemolytic uremic syndrome.

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Eculizumab for congenital atypical hemolytic-uremic syndrome.

P304

63-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/BR.2015.50.1.63

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maitreyee Bhattacharyya

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274401347

http://www.w3.org/2001/XMLSchema#string

P698

25830136

http://www.w3.org/2001/XMLSchema#string

P932

4377346

http://www.w3.org/2001/XMLSchema#string